228.89MMarket Cap-4.60P/E (TTM)
2.330High2.060Low2.97MVolume2.250Open2.220Pre Close6.43MTurnover3.67%Turnover RatioLossP/E (Static)110.57MShares4.20552wk High4.09P/B168.00MFloat Cap0.61352wk Low--Dividend TTM81.16MShs Float26.010Historical High--Div YieldTTM12.15%Amplitude0.613Historical Low2.160Avg Price1Lot Size
Amprius Technologies Stock Forum
Q4 2024 Preliminary Financial Results
Based on preliminary unaudited results, management expects the Company to report the following in respect of its quarterly period ended December 31, 2024:
•Revenue of approximately $10.4 million to $10.6 million
•Net loss of approximately $11.4 million to $11.6 million
•Loss per share of approximately $0.10 per share to $...
$GT Biopharma (GTBP.US)$
$Organovo Holdings (ONVO.US)$
$Amprius Technologies (AMPX.US)$
$Nuvve (NVVE.US)$
$Enveric Biosciences (ENVB.US)$
Amprius Secures $15M Purchase Order for Sicoretm Cells From Leading Uas Manufacturer
- YouTube
I feel they are mavericks in this space and ahead of the pack! excited how much revolution they can bring.
- YouTube
No comment yet